Advanced Medical Solutions Grp PLC Block listing Interim Review (5046M)
September 14 2023 - 9:52AM
UK Regulatory
TIDMAMS
RNS Number : 5046M
Advanced Medical Solutions Grp PLC
14 September 2023
14 September 2023
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Block Listing Interim Review
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the world-leading specialist in tissue-healing technologies , makes
the following notification pursuant to Schedule Six of the AIM
Rules for Companies regarding its existing block admission
arrangements:
Name of applicant: Advanced Medical Solutions Group plc
Name of scheme: Block Scheme for:
1. Deferred Share Bonus Scheme
2. Company Share Option Plan
3. Unapproved Executive Share Option Scheme
4. Long Term Incentive Plan
5. Deferred Annual Bonus Scheme
--------------------------------------------------
Period of return: From: 6 March 2023 To: 5 September 2023
-------------------------- -------------------- ------- -------------------
Balance of unallotted securities under scheme(s) from previous return: 1. 152,679
2. 182,253
3. 586,952
4. 274,107
5. 246,341
--------------------------------------------------
Plus: The amount by which the block scheme(s) has been increased since the 1. Nil
date of the last 2. Nil
return (if any increase has been applied for): 3. Nil
4. Nil
5. Nil
--------------------------------------------------
Less: Number of securities issued/allotted under scheme(s) during period: 1. 85,483
2. 40,710
3. 40,766
4. 47,585
5. Nil
--------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 1. 67,196
2. 141,543
3. 546,186
4. 226,522
5. 246,341
--------------------------------------------------
Number and class of securities originally listed and the date of admission: 4,476,264 ordinary shares of 5p each on 6
September 2018
--------------------------------------------------
Name of contact: Eddie Johnson
Telephone number of contact: 01606 545506
--------------
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Eddie Johnson, Chief Financial Officer
Michael King, Investor Relations
---------------------
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
---------------------
Matthew Neal / Lucy Featherstone
---------------------
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
---------------------
Gary Clarence / David Anderson
---------------------
HSBC Bank plc (Broker) Tel: +44 (0) 20 7991
8888
---------------------
Sam McLennan / Joe Weaving / Stephanie Cornish
---------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRGPURCBUPWGCC
(END) Dow Jones Newswires
September 14, 2023 10:52 ET (14:52 GMT)
Advanced Medical Solutions (AQSE:AMS.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Advanced Medical Solutions (AQSE:AMS.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024
